KNSA:NASDAQ
Kiniksa Pharmaceuticals Internatinl, PLC
US$96,33
arrow_upward
+0,05%(+0,050) 1D
13 ພ.ຈ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KNSA...
Open
US$96,37
High
US$96,75
Low
US$94,50
Mkt. cap
7,57 ຕື້
Avg. vol.
819,14 ພັນ
Volume
0,00
P/E ratio
73,53
52-wk high
US$99,31
52-wk low
US$37,02
EPS
US$1,31
Beta
0,07
Shares outstanding
48,84 ລ້ານ
No. of employees
366
Open
US$96,37
High
US$96,75
Low
US$94,50
Mkt. cap
7,57 ຕື້
Avg. vol.
819,14 ພັນ
Volume
0,00
P/E ratio
73,53
52-wk high
US$99,31
52-wk low
US$37,02
EPS
US$1,31
Beta
0,07
Shares outstanding
48,84 ລ້ານ
No. of employees
366
News stories
From web sources and news partners
investingLive
·
3 ຊົ່ວໂມງກ່ອນ
Morgan Stanley goes max overweight global stocks, sees 15% S&P 500 upside on AI capex
The Motley Fool
·
11 ຊົ່ວໂມງກ່ອນ
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
TradingKey
·
1 ມື້ກ່ອນ
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
BigGo Finance
·
16 ຊົ່ວໂມງກ່ອນ
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
About Kiniksa Pharmaceuticals Internatinl, PLC
CEO-
Employees366
Founded2015
Headquartersລອນດອນ, ປະເທດອັງກິດ, ສະຫະລາດຊະອະນາຈັກ
SectorHealth Care
IndustryBiotechnology
Websitekiniksa.com